Home > Research > Publications & Outputs > Medicine's next goldmine? : The implications of...

Research

Links

Text available via DOI:

Keywords

View graph of relations

Medicine's next goldmine? : The implications of the new genetic health technologies for the health service.

Research output: Contribution to Journal/Magazine › Journal article › peer-review

Published

Standard

Medicine's next goldmine? : The implications of the new genetic health technologies for the health service. / Calnan, Michael; Wainwright, David; Glasner, Peter et al.
In: Medicine, Health Care and Philosophy, Vol. 9, No. 1, 03.2006, p. 33-41.

Research output: Contribution to Journal/Magazine › Journal article › peer-review

Harvard

Calnan, M, Wainwright, D, Glasner, P, Newbury-Ecob, R & Ferlie, E 2006, 'Medicine's next goldmine? : The implications of the new genetic health technologies for the health service.', Medicine, Health Care and Philosophy, vol. 9, no. 1, pp. 33-41. https://doi.org/10.1007/s11019-005-7496-2

APA

Calnan, M., Wainwright, D., Glasner, P., Newbury-Ecob, R., & Ferlie, E. (2006). Medicine's next goldmine? : The implications of the new genetic health technologies for the health service. Medicine, Health Care and Philosophy, 9(1), 33-41. https://doi.org/10.1007/s11019-005-7496-2

Vancouver

Calnan M, Wainwright D, Glasner P, Newbury-Ecob R, Ferlie E. Medicine's next goldmine? : The implications of the new genetic health technologies for the health service. Medicine, Health Care and Philosophy. 2006 Mar;9(1):33-41. doi: 10.1007/s11019-005-7496-2

Author

Calnan, Michael ; Wainwright, David ; Glasner, Peter et al. / Medicine's next goldmine? : The implications of the new genetic health technologies for the health service. In: Medicine, Health Care and Philosophy. 2006 ; Vol. 9, No. 1. pp. 33-41.

Bibtex

@article{c50f25d948e34f05919b8a802d522282,
title = "Medicine's next goldmine? : The implications of the new genetic health technologies for the health service.",
abstract = "There is considerable uncertainty about the implications of the new genetics for health services. These are the enthusiasts who argue that molecular genetics will transform health care and others argue that the scope for genetic interventions is limited. The aim of this paper is to examine some of the questions, tensions and difficulties which face health care providers particularly in developed countries as they try to come to terms with the dilemmas raised by new genetic health care technologies (NGHTs). It identifies questions for research which may help the development of robust and flexible strategies for implementation.",
keywords = "evidence-based - genetic health care technologies - health services - implementation",
author = "Michael Calnan and David Wainwright and Peter Glasner and Ruth Newbury-Ecob and Ewan Ferlie",
year = "2006",
month = mar,
doi = "10.1007/s11019-005-7496-2",
language = "English",
volume = "9",
pages = "33--41",
journal = "Medicine, Health Care and Philosophy",
issn = "1386-7423",
publisher = "Springer Netherlands",
number = "1",

}

RIS

TY - JOUR

T1 - Medicine's next goldmine? : The implications of the new genetic health technologies for the health service.

AU - Calnan, Michael

AU - Wainwright, David

AU - Glasner, Peter

AU - Newbury-Ecob, Ruth

AU - Ferlie, Ewan

PY - 2006/3

Y1 - 2006/3

N2 - There is considerable uncertainty about the implications of the new genetics for health services. These are the enthusiasts who argue that molecular genetics will transform health care and others argue that the scope for genetic interventions is limited. The aim of this paper is to examine some of the questions, tensions and difficulties which face health care providers particularly in developed countries as they try to come to terms with the dilemmas raised by new genetic health care technologies (NGHTs). It identifies questions for research which may help the development of robust and flexible strategies for implementation.

AB - There is considerable uncertainty about the implications of the new genetics for health services. These are the enthusiasts who argue that molecular genetics will transform health care and others argue that the scope for genetic interventions is limited. The aim of this paper is to examine some of the questions, tensions and difficulties which face health care providers particularly in developed countries as they try to come to terms with the dilemmas raised by new genetic health care technologies (NGHTs). It identifies questions for research which may help the development of robust and flexible strategies for implementation.

KW - evidence-based - genetic health care technologies - health services - implementation

U2 - 10.1007/s11019-005-7496-2

DO - 10.1007/s11019-005-7496-2

M3 - Journal article

VL - 9

SP - 33

EP - 41

JO - Medicine, Health Care and Philosophy

JF - Medicine, Health Care and Philosophy

SN - 1386-7423

IS - 1

ER -